Vaccine投稿须知_审稿周期

期刊简介

《Vaccine》是由Elsevier BV出版社于1983年创办的英文国际期刊（ISSN: 0264-410X，E-ISSN: 1358-8745），该期刊长期致力于免疫学领域的创新研究，主要研究方向为医学-免疫学。作为SCIE收录期刊（JCR分区 Q2，中科院 3区），本刊采用OA未开放获取模式（OA占比0.3514...%），以发表免疫学领域等方向的原创性研究为核心（研究类文章占比93.75%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在832篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Vaccine审稿周期约为约4.5个月约10.4周。该刊近年未被列入国际预警名单，年发文量约832篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
832 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 3区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 3区 3区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q2	61 / 181	66.6%
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	52 / 189	72.8%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q1	41 / 181	77.62%
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	46 / 189	75.93%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：8.7

SJR：1.342

SNIP：1.085

学科类别	分区	排名	百分位
大类：Veterinary 小类：General Veterinary	Q1	5 / 194	97%
大类：Veterinary 小类：Public Health, Environmental and Occupational Health	Q1	54 / 665	91%
大类：Veterinary 小类：General Immunology and Microbiology	Q1	10 / 61	84%
大类：Veterinary 小类：Infectious Diseases	Q1	58 / 344	83%
大类：Veterinary 小类：Molecular Medicine	Q2	46 / 178	74%

期刊发文

Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWETM
Author: Xu, Senyu; Duan, Huixin; An, Yaling; Jin, Xiyue; Duan, Minrun; Dubois, Patrice M.; Huang, Yan; Xu, Kun; Du, Heng; Kleanthous, Harry; Dai, Lianpan; Gao, George F.

Journal: VACCINE. 2023; Vol. 41, Issue 17, pp. 2793-2803. DOI: 10.1016/j.vaccine.2023.03.035
Willingness of parents of 9-to-18-year-old females in China to vaccinate their daughters with HPV vaccine
Author: Zhang, Zhaonan; Shi, Jinjing; Zhang, Xixi; Guo, Xu; Yu, Wenzhou

Journal: VACCINE. 2023; Vol. 41, Issue 1, pp. 130-135. DOI: 10.1016/j.vaccine.2022.11.016
Education level modifies parental hesitancy about COVID-19 vaccinations for their children
Author: Tang, Shuning; Liu, Xin; Jia, Yingnan; Chen, Hao; Zheng, Pinpin; Fu, Hua; Xiao, Qianyi

Journal: VACCINE. 2023; Vol. 41, Issue 2, pp. 496-503. DOI: 10.1016/j.vaccine.2022.11.060
What attributes influence rural household's willingness to get vaccinated for COVID-19? Perspectives from six Chinese townships
Author: Sun, Yingying; Huang, Shih-Kai; Arlikatti, Sudha; Lindell, Michael K.

Journal: VACCINE. 2023; Vol. 41, Issue 3, pp. 702-715. DOI: 10.1016/j.vaccine.2022.11.062
Construction of a Lactobacillus plantarum-based claudin-3 targeting delivery system for the development of vaccines against Eimeria tenella
Author: Sun, Lingyu; Zhao, Ningning; Li, Huihui; Wang, Bingxiang; Li, Hongmei; Zhang, Xiao; Zhao, Xiaomin

Journal: VACCINE. 2023; Vol. 41, Issue 3, pp. 756-765. DOI: 10.1016/j.vaccine.2022.12.014
Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study
Author: Guo, Jia; Zhang, Haijun; Zhang, Haonan; Lai, Xiaozhen; Wang, Jiahao; Feng, Huangyufei; Fang, Hai

Journal: VACCINE. 2023; Vol. 41, Issue 3, pp. 716-723. DOI: 10.1016/j.vaccine.2022.12.004
Common issues and improvement solution of vaccine hesitancy in children with underlying neurological conditions: Experience from one National Children's Medical Center in China
Author: Feng, Tianxing; Wang, Xiangshi; Li, Jingjing; Wang, Chuning; Qiu, Yue; Zhang, Ying; Zhou, Beihua; Wang, Jiali; Xia, Aimei; Sun, Xiaodong; Huang, Zhuoying; Wei, Zhongqiu; Wang, Yi; Zeng, Mei

Journal: VACCINE. 2023; Vol. 41, Issue 2, pp. 427-434. DOI: 10.1016/j.vaccine.2022.11.063
Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China
Author: Chen, Shuning; Gao, Shenghui; Li, Jingxin; Li, Jingsong; Duan, Zhao-jun

Journal: VACCINE. 2023; Vol. 41, Issue 2, pp. 547-554. DOI: 10.1016/j.vaccine.2022.11.074

Vaccine

疫苗

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询